Evidence map›Paper›PMID 38420270›Full record

ArticleThe Lancet regional health. Southeast Asia2024

Self-driven solutions and resilience adapted by people with drug-resistant tuberculosis and their caregivers in Bengaluru and Hyderabad, India: a qualitative study.

Karikalan Nagarajan, Karthikeyan Kumarswamy, Rehana Begum, Vikas Panibatla, Anil Singarajipura, Rajesham Adepu, Joseph Francis Munjattu, Senthil Sellapan, Stephen Arangba, Amrita Goswami and 4 more

Open access · diamondAbstract read
In one paragraph

Article in The Lancet regional health. Southeast Asia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Karikalan NagarajanICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India.
Karthikeyan KumarswamyKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Bengaluru, Karnataka, 560044, India.
Rehana BegumKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Bengaluru, Karnataka, 560044, India.
Vikas PanibatlaTB Alert India, Hyderabad, West Marredpally, Secunderabad, Telangana, 500026, India.
Anil SingarajipuraState TB Office, 2nd Floor, Arogya Soudha, Magadi Road, Bengaluru, Karnataka, 560023, India.
Rajesham AdepuState TB Office, Directorate of Medical & Health Services, Hyderabad, Telangana, 500095, India.
Joseph Francis MunjattuKarnataka Health Promotion Trust, IT Park, Rajajinagar Industrial Area, Bengaluru, Karnataka, 560044, India.
Senthil SellapanICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India.
Stephen ArangbaICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India.
Amrita GoswamiInfectious Disease Division, New Delhi, USAID, India.
Reuben SwamickanInfectious Disease Division, New Delhi, USAID, India.
Javeed BashaICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India.
Pearl Maria DsouzaICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India.
Malaisamy MuniyandiICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India.
National Institute of Research in Tuberculosis · INKarnataka Health Promotion Trust · INNew Delhi Tuberculosis Center · INGovernment of Andhra Pradesh · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: One-fifth of people with drug-resistance tuberculosis (DR-TB) who were initiated on newer shorter treatment regimen (with injection) had unfavourable treatment outcomes in India as on 2020. Evidence on self-driven solutions and resilience adapted by people with DR-TB (PwDR-TB) towards their multi-dimensional disease and treatment challenges are scarce globally, which we aimed to understand. Methods: In this qualitative study using positive deviance framework, we conducted semi-structured in-depth interviews among consenting adult PwDR-TB (7 women, 13 men) who completed shorter treatment regimen (including injections) with maximum treatment adherence. The study was conducted in the southern districts of Bengaluru and Hyderabad, India between June 2020 and December 2022. Caregivers (14 women, 6 men) and health providers (8 men, 2 women) of PwDR-TB were also interviewed. Interviews were conducted in local language (Kannada, Tamil, Telugu, Urdu and Hindi) and inquired about practices, behaviours, experiences, perceptions and attributes which enabled maximum adherence and resilience of PwDR-TB. Interviews were audio recorded, transcribed, and translated to English and coded for thematic analysis using inductive approach. Findings: Distinctive themes explanatory of the self-driven solutions and resilience exhibited by PwDR-TB and their caregivers were identified: (i) Self-adaptation towards the biological consequences of drugs, by personalised nutritional and adjuvant practices, which helped to improve drug ingestion and therapeutic effects. Also home remedies and self-plans for ameliorating injection pain. (ii) Perceptual adaptation towards drugs aversion and fatigue, by their mind diversion practices, routinisation and normalisation of drug intake process. and constant reinforcement and re-interpretation of bodily signs of disease recovery (iii) Family caregivers intense and participatory care for PwDR-TB, by aiding their essential life activities and ensuring survival, learning and fulfilling special nutritional needs and goal oriented actions to aid drug intake (iv) Health care providers care, marked by swift and timely risk mitigation of side-effects and crisis response (v) Acquired self-efficacy of PwDR-TB, by their decisive family concerns resulting in attitudinal change. Also being sensitised on the detrimental consequences of disease and being motivated through positive examples. Interpretation: Synthesised findings on self-driven solutions and resilience towards the multi-dimensional DR-TB challenges provides opportunity for developing and testing new interventions for its effectiveness in DR-TB care settings globally. Designing and testing personalised cognitive interventions for PwDR-TB: to inculcate attitudinal change and self-efficacy towards medication, developing cognitive reinforcements to address the perception burden of treatment, skill building and mainstreaming the role of family caregivers as therapeutic partners of PwDR-TB, curating self-adaptive behaviours and practices of PwDR-TB to normalise their drug consumptions experiences could be the way forward in building resilience towards DR-TB. Funding: United States Agency for International Development (USAID) through Karnataka Health Promotion Trust (KHPT), Bengaluru, India.

Indexed as

AdaptationsCareDrug-resistanceIndiaPerson-centeredPositive devianceQualitativeResilienceSelf-driven solutionsSelf-efficacySolutionsTuberculosis

Identifiers

PMID38420270
PMCPMC10900834
OpenAlexW4392009843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.